SABBY MANAGEMENT LLC 13D/13G Filings for SUNESIS PHARMACEUTICALS INC CO (SNSS)

SABBY MANAGEMENT LLC 13D and 13G filings for SUNESIS PHARMACEUTICALS INC CO:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2020-07-29
11:06 am
Purchase
2020-07-29 13G SUNESIS PHARMACEUTICALS INC CO
SNSS
SABBY MANAGEMENT LLC 10,869,565
11.000%
10,869,565increase
(New Position)
Filing